Фенотипирование бронхиальной астмы с элементами эндотипирования: перспективы развития направления

1. Chung et al. Difficult-to-treat Severe Asthma. European Respiratory Monograph 51 (Book), 2011.
2. S. Hashimoto EH. Bel Current treatment of severe asthma. Clin Expl Allergy; 42 (5): 693–705.
3. Wenzel S. Severe asthma: from characteristics to phenotypes to endotypes. Clin Exp Allergy 2012; 42 (5): 650–8.
4. Agache I, Akdis C et al. Untangling asthma phenotypes and endotypes. Allergy 2012; 67 (7): 835–46.
5. Wenzel S. Focus on Asthma. Nature Med 2012; 18: 5.
6. Wenzel S. E Phenotypes in Asthma Useful Guides for Therapy, Distinct Biological processes, or both? Am J Respir Crit Care Med 2004; 170: 579–80.
7. Wensel S. E Review Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804–13.
8. Kharitonov SA, Barnes PJ. Exhaled biomarker. Chest 2006; 130 (5): 1541–6.
9. Дугарова И.Д., Анаев Э.Х., Чучалин А.Г. О роли цитокинов при бронхиальной астме. Пульмонология. 2009; 4: 92–102.
10. Vrlik M, Dzurilla M, Bucova M et al. Asthma bronchiale phenotypes and their treatment – a current view. Acta Med Mart 2009; 9 (3): 3–1137.
11. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma. Insights from clinical studies. Proc Am Thorac Soc 2009; 6: 256–9.
12. Tillie-Leblond, Montani D, Crestani B et al. Relation between inflammation and symptoms in asthma. Allergy J Comp Blackwell Munksgaard 2009.
13. Cowan DC, Cowan J, Palmay R et al. The effects of steroid therapy on inflammatory cell subtypes in asthma. 2010. Downloaded from thorax.bmj.com on February 4, 2010-Published by group.bmj.com.
14. Berry M, Morgan A, Shaw D et al. Рathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62 (12): 1043–9.
15. Cowan DC, Cowan J, Palmay R et al. the effects of steroid therapy on inflammatory cell subtypes in asthma. 2010. Downloaded from thorax.bmj.com on February 4, 2010-Published by group.bmj.com.
16. Telenga E et al. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy 2012; 67 (8): 1060–8.
17. McGrath KW et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir 2012; 185: 612–9.
18. Macedo P, Hew M, Norrego A et al. Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma. Clin Exp Allergy 2009; 39: 1668–76.
19. Hastie AT, Moore WC, Meyers DA et al. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 2010; 1028–36.
20. Lavinskiene S et al. Peripheral Blood Neutrophil Activity During Dermatophagoides pteronyssinus-Induced Late-Phase Airway Inflammation in Patients with Allergic Rhinitis and Asthma. Inflammation 2012; 35 (4): 1600–9.
21. Cosmi L, Liotta F, Maggi E et al. TH17 cells: new players in asthma pathogenesis. Allergy 2011; 989–8.
22. Innovative Medicines Initiative (MIM). http://www.imi.europa.eul/.
23. Аuffray C, Adcock IM, Chung F et al. An integrative systems biology approach for understanding of pulmonary disease. Chest 2010; 137: 1410–16.

Д.С.Фомина, О.С.Дробик, Л.А.Горячкина 

ГБОУ ДПО Российская медицинская академия последипломного образования, Москва